Panora Robert A's Form 4/A amendment
AmendedTecogen Inc. (TGEN) · filed Jul 14, 2025
- Accession no.
- 0001537435-25-000071
- Filed
- Jul 14, 2025
- Trade date
- Jun 3-24, 2025
- Filing delay
- 41 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 20, 2025
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $550.8K. It was filed 41 days after the trade.
This amendment replaces 0001537435-25-000058 (filed Jun 20, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Panora Robert ACIK 0001585814 | Officer (COO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Common Stock | SSaleDisposed | −26,000 | $4.69 | −$121,940 | 44,000 | Direct | |
| Jun 4, 2025 | Common Stock | SSaleDisposed | −31,000 | $5.00 | −$155,000 | 13,000 | Direct | |
| Jun 16, 2025 | Common Stock | MOption exerciseAcquired | +12,723 | $0.79 | +$10,051.17 | 25,723 | Direct | |
| Jun 16, 2025 | Common Stock | MOption exerciseAcquired | +30,000 | $0.71 | +$21,300 | 55,723 | Direct | |
| Jun 16, 2025 | Common Stock | MOption exerciseAcquired | +52,500 | $1.10 | +$57,750 | 108,223 | Direct | |
| Jun 18, 2025 | Common Stock | SSaleDisposed | −13,000 | $5.03 | −$65,390 | 95,223 | Direct | |
| Jun 23, 2025 | Common Stock | SSaleDisposed | −31,800 | $6.36 | −$202,248 | 63,423 | Direct | |
| Jun 24, 2025 | Common Stock | SSaleDisposed | −900 | $6.86 | −$6,174 | 62,523 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseDisposed | −12,723 | $0.79 | −$10,051.17 | 0 | Direct | |
| Jun 16, 2025 | Common Stock | MOption exerciseDisposed | −30,000 | $0.71 | −$21,300 | 100,000 | Direct | |
| Jun 16, 2025 | Common Stock | MOption exerciseDisposed | −52,500 | $1.10 | −$57,750 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Share sales effected to cover tax liabilities and other obligations. The June 2025 share sales were reported to the company on July 11, 2025.
- F2
Transaction code corrected
- F3
100,000 shares of the 200,000 option shares granted pursuant to Stock Option Agreement dated 7/9/2020 vested on 6/30/2022 upon achievement of Adjusted EBITDA performance milestone.